Mingwang Huang

Title: Innovations of Mingwang Huang in Pharmaceutical Chemistry

Introduction

Mingwang Huang is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for the synthesis of important medications. His work is characterized by innovative approaches that enhance the efficiency and effectiveness of drug production.

Latest Patents

Mingwang Huang holds a patent for "Intermediates of sitagliptin and preparation process thereof." This patent discloses intermediates of Sitagliptin, a preparation process for these intermediates, and a method for synthesizing Sitagliptin using them. The synthesis of Sitagliptin is achieved by utilizing chiral amino compounds as raw materials, which eliminates the need for building a chiral center through chiral asymmetric catalytic hydrogenation. Additionally, high-pressure hydrogenation is avoided, making the process more efficient.

Career Highlights

Mingwang Huang is currently associated with Zhejiang Hisoar Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative work has led to advancements in the synthesis of important pharmaceutical compounds, contributing to the overall progress in the industry.

Collaborations

Mingwang Huang collaborates with Xianhua Pan, a fellow professional in the field. Their partnership enhances the research and development efforts at Zhejiang Hisoar Pharmaceutical Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Mingwang Huang's contributions to pharmaceutical chemistry, particularly through his patent on Sitagliptin intermediates, showcase his innovative spirit and dedication to improving drug synthesis processes. His work continues to impact the pharmaceutical industry positively.